Immunogenicity and safety of a two-dose regimen of a combined measles, mumps, rubella and varicella live vaccine (ProQuad(®)) in infants from 9 months of age

Julkaisu

Reference

Vesikari T, Becker T, Gajdos V, et al. Immunogenicity and safety of a two-dose regimen of a combined measles, mumps, rubella and varicella live vaccine (ProQuad(®)) in infants from 9 months of age. Vaccine 2012:30(20):3082-3089.

Julkaisutiedot

Julkaisutyyppi: Alkuperäisartikkeli.
Kansainvälinen.
Kieli: Englanti.

Teksti/tiivistelmä: https://www.ncbi.nlm.nih.gov/pubmed/22406278

Publication data

Publication type: Original scientific article.
International.
In English.

Text/summary: https://www.ncbi.nlm.nih.gov/pubmed/22406278

Tekijät

Contributors

Tampereen yliopisto

Lääketieteen laitos/virologia 1
- Timo Vesikari

University of Tampere

Medical School/Department of Virology 1
- Timo Vesikari

Tampereen yliopistollinen sairaala

Lastentautien vastuualue
- Timo Vesikari

Tampere University Hospital

Julkaisutietokanta 8.1.2013

Publications Data Base 8.1.2013